The Library
Inconsistencies in the development of the ESC Clinical Practice Guidelines for Heart Failure
Tools
Coats, Andrew J. S. and Shewan, Louise G. (2013) Inconsistencies in the development of the ESC Clinical Practice Guidelines for Heart Failure. International Journal of Cardiology, Volume 168 (Number 3). pp. 1724-1727. doi:10.1016/j.ijcard.2013.05.045 ISSN 0167-5273.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1016/j.ijcard.2013.05.045
Abstract
The publication of the European Society of Cardiology (ESC) guidelines for the management of heart failure, in 2012 represented the latest and arguably the most comprehensive document to date summarising recommended treatment and diagnostic options for the care of heart failure patients. The impact of clinical practice guidelines is now so great that it is important to review the processes that underlie guideline development. The ESC guideline process is compared and contrasted to those of other guideline bodies. The ESC uses its own internal experts inclined to review source clinical trial data rather than published or commissioned meta-analyses and systematic reviews. Uncertainties exist in several areas, such as how are the scope of potential treatments to be reviewed chosen, if there is no call for proposals or external consultation?, Two illustrative discrepancies are highlighted i) the non-surgical MitraClip device for reducing mitral regurgitation is given the verbal equivalent of a Class IIb recommendation on the basis of 107 patients in an uncontrolled registry, whereas no drug is reviewed based on such data, and another device, the subject of 3 prospective randomised controlled trials, was not reviewed at all and ii) for Ivabradine the whole trial population was included in the recommendation, despite a subgroup not benefitting, whereas for CRT the sub-group not thought to benefit was excluded from the recommendation. We propose that more interaction is needed between ESC and stakeholders so each can better understand the processes for producing guidelines to improve some of these aspects.
Item Type: | Journal Article | ||||
---|---|---|---|---|---|
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School | ||||
Journal or Publication Title: | International Journal of Cardiology | ||||
Publisher: | Elsevier Ireland Ltd. | ||||
ISSN: | 0167-5273 | ||||
Official Date: | 2013 | ||||
Dates: |
|
||||
Volume: | Volume 168 | ||||
Number: | Number 3 | ||||
Page Range: | pp. 1724-1727 | ||||
DOI: | 10.1016/j.ijcard.2013.05.045 | ||||
Status: | Peer Reviewed | ||||
Publication Status: | Published | ||||
Access rights to Published version: | Restricted or Subscription Access |
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |